Cover Image
Market Research Report
Product code 
1039002

Liquid Biopsy Market Size By Biomarkers, By Product, By Application, COVID-19 Impact Analysis, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2021 - 2027

Published: | Global Market Insights Inc. | 130 Pages | Delivery time: 2-3 business days

Price

Back to Top
Liquid Biopsy Market Size By Biomarkers, By Product, By Application, COVID-19 Impact Analysis, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2021 - 2027
Published: November 29, 2021
Global Market Insights Inc.
Content info: 130 Pages
Delivery time: 2-3 business days
  • Description
  • Table of Contents
  • List of Tables

The liquid biopsy market is projected to exhibit robust expansion by 2027 owing to growing preference for non-invasive diagnostic methods among patients across the world.

Liquid biopsy refers to a blood test that looks for cancer cells from a tumor that are circulating in the blood or DNA fragments from tumor cells, which are present in the blood. It has been shown to aid in the detection of cancer even in the early stages. Additionally, it is also used to help plan treatment, understand how well treatment is working, and determine if cancer has returned. Rising awareness among patients, particularly high-risk individuals, about early disease diagnosis and periodic checkups has fostered industry uptake in recent years.

Furthermore, industry players have been actively employing lucrative strategies to gain a competitive edge in the emerging sector, which has positively impacted liquid biopsy market dynamics. For instance, in November 2021, Lucence Health, a leading precision oncology company, entered into a partnership agreement with VA Palo Alto Healthcare System, a prominent oncology firm, to launch its first liquid biopsy technology study in the U.S. The study intends to examine the use of non-invasive liquid biopsy in conjunction with imaging technologies for the detection of lung cancer in high-risk individuals.

The liquid biopsy market has been segregated on the basis of application, biomarkers, product, and region. In terms of biomarkers, the market has further been divided into circulating tumor DNA, circulating tumor cells (CTC), and others.

The circulating tumor cells (CTC) sub-segment is expected to reach a notable valuation by 2027, expanding at approximately 29.7% CAGR over the study timeline propelled by the high specificity of CTC. Moreover, increased risk of metastatic conditions, along with organizational efforts to expand accessibility, is likely to drive segmental growth in the coming years.

Based on product, the liquid biopsy market has been classified into assay & panels, kits & reagents, and others. The others sub-segment is set to grow at a stable pace over 2021-2027 driven by the development of specific instruments to offer ease in complex procedures and manage workflow.

With respect to application, the market has been categorized into prostate cancer, lung cancer, colorectal cancer, breast cancer, and others. In 2020, the prostate cancer sub-segment held over 9% share in the liquid biopsy market and is estimated to witness steady growth over the analysis period. Higher disease prevalence in developing countries has prompted the adoption of advanced diagnostic methods, which is slated to fuel segmental demand in coming years.

From the regional point of view, the Latin America liquid biopsy market is poised to grow at a CAGR of around 29.4% over the assessment timeline. Mounting emphasis of industry players on business expansion to broaden product accessibility in LATAM is speculated to propel regional market growth over the forthcoming years.

Product Code: 3775

Table of Contents

Chapter 1 Methodology

  • 1.1 Market definitions
  • 1.2 Base estimates & working
    • 1.2.1 North America
    • 1.2.2 Europe
    • 1.2.3 Asia Pacific
    • 1.2.4 Latin America
    • 1.2.5 Middle East and Africa
  • 1.3 Forecast calculations
  • 1.4 Data validation
  • 1.5 Data sources
    • 1.5.1 Secondary
      • 1.5.1.1 Paid sources
      • 1.5.1.2 Unpaid sources
    • 1.5.2 Primary

Chapter 2 Executive Summary

  • 2.1 Liquid biopsy industry 360 degree synopsis, 2016 - 2027 (USD Million)
    • 2.1.1 Business trends
    • 2.1.2 Biomarkers trends
    • 2.1.3 Product trends
    • 2.1.4 Application trends
    • 2.1.5 Regional trends

Chapter 3 Liquid Biopsy Industry Insights

  • 3.1 Industry segmentation
  • 3.2 Industry landscape, 2016 - 2027 (USD Million)
  • 3.3 Industry impact forces
    • 3.3.1 Growth drivers
      • 3.3.1.1 Continuous technological advancements in cancer diagnostics
      • 3.3.1.2 Increasing preference for non-invasive disease diagnosis
      • 3.3.1.3 Growing prevalence of cancer worldwide
      • 3.3.1.4 Rising awareness regarding early disease diagnosis
    • 3.3.2 Industry pitfalls & challenges
      • 3.3.2.1 Stringent regulatory framework
      • 3.3.2.2 Lack of skilled professionals
  • 3.4 Growth potential analysis
    • 3.4.1 By biomarkers
    • 3.4.2 By product
    • 3.4.3 By application
  • 3.5 COVID-19 impact analysis
  • 3.6 Service provider landscape
  • 3.7 Porter's analysis
  • 3.8 Competitive landscape, 2020
  • 3.9 PESTEL analysis

Chapter 4 Liquid Biopsy Market, By Biomarkers

  • 4.1 Key segment trends
  • 4.2 Circulating tumor cells (CTC)
    • 4.2.1 Market size, by region, 2016 - 2027 (USD Million)
  • 4.3 Circulating tumor DNA (ctDNA)
    • 4.3.1 Market size, by region, 2016 - 2027 (USD Million)
  • 4.4 Others
    • 4.4.1 Market size, by region, 2016 - 2027 (USD Million)

Chapter 5 Liquid Biopsy Market, By Product

  • 5.1 Key segment trends
  • 5.2 Kits & reagents
    • 5.2.1 Market size, by region, 2016 - 2027 (USD Million)
  • 5.3 Assay & panels
    • 5.3.1 Market size, by region, 2016 - 2027 (USD Million)
  • 5.4 Others
    • 5.4.1 Market size, by region, 2016 - 2027 (USD Million)

Chapter 6 Liquid Biopsy Market, By Application

  • 6.1 Key segment trends
  • 6.2 Lung cancer
    • 6.2.1 Market size, by region, 2016 - 2027 (USD Million)
  • 6.3 Breast cancer
    • 6.3.1 Market size, by region, 2016 - 2027 (USD Million)
  • 6.4 Colorectal cancer
    • 6.4.1 Market size, by region, 2016 - 2027 (USD Million)
  • 6.5 Prostate cancer
    • 6.5.1 Market size, by region, 2016 - 2027 (USD Million)
  • 6.6 Others
    • 6.6.1 Market size, by region, 2016 - 2027 (USD Million)

Chapter 7 Liquid Biopsy Market, By Region

  • 7.1 Key regional trends
  • 7.2 North America
    • 7.2.1 Market size by country, 2016 - 2027 (USD Million)
    • 7.2.2 Market size by biomarkers, 2016 - 2027 (USD Million)
    • 7.2.3 Market size by product, 2016 - 2027 (USD Million)
    • 7.2.4 Market size by application, 2016 - 2027 (USD Million)
    • 7.2.5 U.S.
      • 7.2.5.1 Market size by biomarkers, 2016 - 2027 (USD Million)
      • 7.2.5.2 Market size by product, 2016 - 2027 (USD Million)
      • 7.2.5.3 Market size by application, 2016 - 2027 (USD Million)
    • 7.2.6 Canada
      • 7.2.6.1 Market size by biomarkers, 2016 - 2027 (USD Million)
      • 7.2.6.2 Market size by product, 2016 - 2027 (USD Million)
      • 7.2.6.3 Market size by application, 2016 - 2027 (USD Million)
  • 7.3 Europe
    • 7.3.1 Market size by country, 2016 - 2027 (USD Million)
    • 7.3.2 Market size by biomarkers, 2016 - 2027 (USD Million)
    • 7.3.3 Market size by product, 2016 - 2027 (USD Million)
    • 7.3.4 Market size by application, 2016 - 2027 (USD Million)
    • 7.3.5 Germany
      • 7.3.5.1 Market size by biomarkers, 2016 - 2027 (USD Million)
      • 7.3.5.2 Market size by product, 2016 - 2027 (USD Million)
      • 7.3.5.3 Market size by application, 2016 - 2027 (USD Million)
    • 7.3.6 UK
      • 7.3.6.1 Market size by biomarkers, 2016 - 2027 (USD Million)
      • 7.3.6.2 Market size by product, 2016 - 2027 (USD Million)
      • 7.3.6.3 Market size by application, 2016 - 2027 (USD Million)
    • 7.3.7 France
      • 7.3.7.1 Market size by biomarkers, 2016 - 2027 (USD Million)
      • 7.3.7.2 Market size by product, 2016 - 2027 (USD Million)
      • 7.3.7.3 Market size by application, 2016 - 2027 (USD Million)
    • 7.3.8 Italy
      • 7.3.8.1 Market size by biomarkers, 2016 - 2027 (USD Million)
      • 7.3.8.2 Market size by product, 2016 - 2027 (USD Million)
      • 7.3.8.3 Market size by application, 2016 - 2027 (USD Million)
    • 7.3.9 Spain
      • 7.3.9.1 Market size by biomarkers, 2016 - 2027 (USD Million)
      • 7.3.9.2 Market size by product, 2016 - 2027 (USD Million)
      • 7.3.9.3 Market size by application, 2016 - 2027 (USD Million)
  • 7.4 Asia Pacific
    • 7.4.1 Market size by country, 2016 - 2027 (USD Million)
    • 7.4.2 Market size by biomarkers, 2016 - 2027 (USD Million)
    • 7.4.3 Market size by product, 2016 - 2027 (USD Million)
    • 7.4.4 Market size by application, 2016 - 2027 (USD Million)
    • 7.4.5 Japan
      • 7.4.5.1 Market size by biomarkers, 2016 - 2027 (USD Million)
      • 7.4.5.2 Market size by product, 2016 - 2027 (USD Million)
      • 7.4.5.3 Market size by application, 2016 - 2027 (USD Million)
    • 7.4.6 China
      • 7.4.6.1 Market size by biomarkers, 2016 - 2027 (USD Million)
      • 7.4.6.2 Market size by product, 2016 - 2027 (USD Million)
      • 7.4.6.3 Market size by application, 2016 - 2027 (USD Million)
    • 7.4.7 India
      • 7.4.7.1 Market size by biomarkers, 2016 - 2027 (USD Million)
      • 7.4.7.2 Market size by product, 2016 - 2027 (USD Million)
      • 7.4.7.3 Market size by application, 2016 - 2027 (USD Million)
  • 7.5 Latin America
    • 7.5.1 Market size by country, 2016 - 2027 (USD Million)
    • 7.5.2 Market size by biomarkers, 2016 - 2027 (USD Million)
    • 7.5.3 Market size by product, 2016 - 2027 (USD Million)
    • 7.5.4 Market size by application, 2016 - 2027 (USD Million)
    • 7.5.5 Brazil
      • 7.5.5.1 Market size by biomarkers, 2016 - 2027 (USD Million)
      • 7.5.5.2 Market size by product, 2016 - 2027 (USD Million)
      • 7.5.5.3 Market size by application, 2016 - 2027 (USD Million)
    • 7.5.6 Mexico
      • 7.5.6.1 Market size by biomarkers, 2016 - 2027 (USD Million)
      • 7.5.6.2 Market size by product, 2016 - 2027 (USD Million)
      • 7.5.6.3 Market size by application, 2016 - 2027 (USD Million)
  • 7.6 Middle East & Africa
    • 7.6.1 Market size by country, 2016 - 2027 (USD Million)
    • 7.6.2 Market size by biomarkers, 2016 - 2027 (USD Million)
    • 7.6.3 Market size by product, 2016 - 2027 (USD Million)
    • 7.6.4 Market size by application, 2016 - 2027 (USD Million)
    • 7.6.5 South Africa
      • 7.6.5.1 Market size by biomarkers, 2016 - 2027 (USD Million)
      • 7.6.5.2 Market size by product, 2016 - 2027 (USD Million)
      • 7.6.5.3 Market size by application, 2016 - 2027 (USD Million)
    • 7.6.6 Saudi Arabia
      • 7.6.6.1 Market size by biomarkers, 2016 - 2027 (USD Million)
      • 7.6.6.2 Market size by product, 2016 - 2027 (USD Million)
      • 7.6.6.3 Market size by application, 2016 - 2027 (USD Million)

Chapter 8 Company Profiles

  • 8.1 Competitive dashboard, 2020
  • 8.2 QIAGEN
    • 8.2.1 Business overview
    • 8.2.2 Financial data
    • 8.2.3 Product landscape
    • 8.2.4 Strategic outlook
    • 8.2.5 SWOT analysis
  • 8.3 BIOCEPT, Inc.
    • 8.3.1 Business overview
    • 8.3.2 Financial data
    • 8.3.3 Product landscape
    • 8.3.4 Strategic outlook
    • 8.3.5 SWOT analysis
  • 8.4 Myriad Genetics, Inc.
    • 8.4.1 Business overview
    • 8.4.2 Financial data
    • 8.4.3 Product landscape
    • 8.4.4 Strategic outlook
    • 8.4.5 SWOT analysis
  • 8.5 Guardant Health, Inc.
    • 8.5.1 Business overview
    • 8.5.2 Financial data
    • 8.5.3 Product landscape
    • 8.5.4 Strategic outlook
    • 8.5.5 SWOT analysis
  • 8.6 Illumina, Inc.
    • 8.6.1 Business overview
    • 8.6.2 Financial data
    • 8.6.3 Product landscape
    • 8.6.4 Strategic outlook
    • 8.6.5 SWOT analysis
  • 8.7 F. Hoffmann La Roche Ltd.
    • 8.7.1 Business overview
    • 8.7.2 Financial data
    • 8.7.3 Product landscape
    • 8.7.4 Strategic outlook
    • 8.7.5 SWOT analysis
  • 8.8 Thermo Fisher Scientific, Inc.
    • 8.8.1 Business overview
    • 8.8.2 Financial data
    • 8.8.3 Product landscape
    • 8.8.4 Strategic outlook
    • 8.8.5 SWOT analysis
  • 8.9 Angle plc.
    • 8.9.1 Business overview
    • 8.9.2 Financial data
    • 8.9.3 Product landscape
    • 8.9.4 Strategic outlook
    • 8.9.5 SWOT analysis
  • 8.10 Oncimmune
    • 8.10.1 Business overview
    • 8.10.2 Financial data
    • 8.10.3 Product landscape
    • 8.10.4 Strategic outlook
    • 8.10.5 SWOT analysis
  • 8.11 EPIGENOMICS AG
    • 8.11.1 Business overview
    • 8.11.2 Financial data
    • 8.11.3 Product landscape
    • 8.11.4 Strategic outlook
    • 8.11.5 SWOT analysis
  • 8.12 Lucene Health Inc.
    • 8.12.1 Business overview
    • 8.12.2 Financial data
    • 8.12.3 Product landscape
    • 8.12.4 Strategic outlook
    • 8.12.5 SWOT analysis
  • 8.13 Freenome Holdings, Inc.
    • 8.13.1 Business overview
    • 8.13.2 Financial data
    • 8.13.3 Product landscape
    • 8.13.4 Strategic outlook
    • 8.13.5 SWOT analysis
  • 8.14 MDxHealth SA
    • 8.14.1 Business overview
    • 8.14.2 Financial data
    • 8.14.3 Product landscape
    • 8.14.4 Strategic outlook
    • 8.14.5 SWOT analysis
  • 8.15 Bio RAD Laboratories Inc.
    • 8.15.1 Business overview
    • 8.15.2 Financial data
    • 8.15.3 Product landscape
    • 8.15.4 Strategic outlook
    • 8.15.5 SWOT analysis
  • 8.16 Menarini Silicon Biosystems
    • 8.16.1 Business overview
    • 8.16.2 Financial data
    • 8.16.3 Product landscape
    • 8.16.4 Strategic outlook
    • 8.16.5 SWOT analysis

Data Tables

  • TABLE 1 Global liquid biopsy market, 2016 - 2020 (USD Million)
  • TABLE 2 Global liquid biopsy market, 2021 - 2027 (USD Million)
  • TABLE 3 Global liquid biopsy market, by biomarkers, 2016 - 2020 (USD Million)
  • TABLE 4 Global liquid biopsy market, by biomarkers, 2021 - 2027 (USD Million)
  • TABLE 5 Global liquid biopsy market, by product, 2016 - 2020 (USD Million)
  • TABLE 6 Global liquid biopsy market, by product, 2021 - 2027 (USD Million)
  • TABLE 7 Global liquid biopsy market, by application, 2016 - 2020 (USD Million)
  • TABLE 8 Global liquid biopsy market, by application, 2021 - 2027 (USD Million)
  • TABLE 9 Global liquid biopsy market, by region, 2016 - 2020 (USD Million)
  • TABLE 10 Global liquid biopsy market, by region, 2021 - 2027 (USD Million)
  • TABLE 11 Industry impact forces
  • TABLE 12 Circulating tumor cells market size, by region, 2016 - 2020 (USD Million)
  • TABLE 13 Circulating tumor cells market size, by region, 2021 - 2027 (USD Million)
  • TABLE 14 Circulating tumor DNA market size, by region, 2016 - 2020 (USD Million)
  • TABLE 15 Circulating tumor DNA market size, by region, 2021 - 2027 (USD Million)
  • TABLE 16 Others market size, by region, 2016 - 2020 (USD Million)
  • TABLE 17 Others market size, by region, 2021 - 2027 (USD Million)
  • TABLE 18 Kits & reagents market size, by region, 2016 - 2020 (USD Million)
  • TABLE 19 kits & reagents market size, by region, 2021 - 2027 (USD Million)
  • TABLE 20 Assay & panels market size, by region, 2016 - 2020 (USD Million)
  • TABLE 21 Assay & panels market size, by region, 2021 - 2027 (USD Million)
  • TABLE 22 Others market size, by region, 2016 - 2020 (USD Million)
  • TABLE 23 Others market size, by region, 2021 - 2027 (USD Million)
  • TABLE 24 Lung cancer market size, by region, 2016 - 2020 (USD Million)
  • TABLE 25 Lung cancer market size, by region, 2021 - 2027 (USD Million)
  • TABLE 26 Breast cancer market size, by region, 2016 - 2020 (USD Million)
  • TABLE 27 Breast cancer market size, by region, 2021 - 2027 (USD Million)
  • TABLE 28 Colorectal cancer market size, by region, 2016 - 2020 (USD Million)
  • TABLE 29 Colorectal cancer market size, by region, 2021 - 2027 (USD Million)
  • TABLE 30 Prostate cancer market size, by region, 2016 - 2020 (USD Million)
  • TABLE 31 Prostate cancer market size, by region, 2021 - 2027 (USD Million)
  • TABLE 32 Others market size, by region, 2016 - 2020 (USD Million)
  • TABLE 33 Others market size, by region, 2021 - 2027 (USD Million)
  • TABLE 34 North America liquid biopsy market, by country, 2016 - 2020 (USD Mn)
  • TABLE 35 North America liquid biopsy market, by country, 2021 - 2027 (USD Mn)
  • TABLE 36 North America liquid biopsy market, by biomarkers, 2016 - 2020 (USD Mn)
  • TABLE 37 North America liquid biopsy market, by biomarkers, 2021 - 2027 (USD Mn)
  • TABLE 38 North America liquid biopsy market, by product, 2016 - 2020 (USD Mn)
  • TABLE 39 North America liquid biopsy market, by product, 2021 - 2027 (USD Mn)
  • TABLE 40 North America liquid biopsy market, by application, 2016 - 2020 (USD Mn)
  • TABLE 41 North America liquid biopsy market, by application, 2021 - 2027 (USD Mn)
  • TABLE 42 U.S. liquid biopsy market, by biomarkers, 2016 - 2020 (USD Mn)
  • TABLE 43 U.S. liquid biopsy market, by biomarkers, 2021 - 2027 (USD Mn)
  • TABLE 44 U.S. liquid biopsy market, by product, 2016 - 2020 (USD Mn)
  • TABLE 45 U.S. liquid biopsy market, by product, 2021 - 2027 (USD Mn)
  • TABLE 46 U.S. liquid biopsy market, by application, 2016 - 2020 (USD Mn)
  • TABLE 47 U.S. liquid biopsy market, by application, 2021 - 2027 (USD Mn)
  • TABLE 48 Canada liquid biopsy market, by biomarkers, 2016 - 2020 (USD Mn)
  • TABLE 49 Canada liquid biopsy market, by biomarkers, 2021 - 2027 (USD Mn)
  • TABLE 50 Canada liquid biopsy market, by product, 2016 - 2020 (USD Mn)
  • TABLE 51 Canada liquid biopsy market, by product, 2021 - 2027 (USD Mn)
  • TABLE 52 Canada liquid biopsy market, by application, 2016 - 2020 (USD Mn)
  • TABLE 53 Canada liquid biopsy market, by application, 2021 - 2027 (USD Mn)
  • TABLE 54 Europe liquid biopsy market size, by country, 2016 - 2020 (USD Mn)
  • TABLE 55 Europe liquid biopsy market size, by country, 2021 - 2027 (USD Mn)
  • TABLE 56 Europe liquid biopsy market, by biomarkers, 2016 - 2020 (USD Mn)
  • TABLE 57 Europe liquid biopsy market, by biomarkers, 2021 - 2027 (USD Mn)
  • TABLE 58 Europe liquid biopsy market, by product, 2016 - 2020 (USD Mn)
  • TABLE 59 Europe liquid biopsy market, by product, 2021 - 2027 (USD Mn)
  • TABLE 60 Europe liquid biopsy market, by application, 2016 - 2020 (USD Mn)
  • TABLE 61 Europe liquid biopsy market, by application, 2021 - 2027 (USD Mn)
  • TABLE 62 Germany liquid biopsy market, by biomarkers, 2016 - 2020 (USD Mn)
  • TABLE 63 Germany liquid biopsy market, by biomarkers, 2021 - 2027 (USD Mn)
  • TABLE 64 Germany liquid biopsy market, by product, 2016 - 2020 (USD Mn)
  • TABLE 65 Germany liquid biopsy market, by product, 2021 - 2027 (USD Mn)
  • TABLE 66 Germany liquid biopsy market, by application, 2016 - 2020 (USD Mn)
  • TABLE 67 Germany liquid biopsy market, by application, 2021 - 2027 (USD Mn)
  • TABLE 68 UK liquid biopsy market, by biomarkers, 2016 - 2020 (USD Mn)
  • TABLE 69 UK liquid biopsy market, by biomarkers, 2021 - 2027 (USD Mn)
  • TABLE 70 UK liquid biopsy market, by product, 2016 - 2020 (USD Mn)
  • TABLE 71 UK liquid biopsy market, by product, 2021 - 2027 (USD Mn)
  • TABLE 72 UK liquid biopsy market, by application, 2016 - 2020 (USD Mn)
  • TABLE 73 UK liquid biopsy market, by application, 2021 - 2027 (USD Mn)
  • TABLE 74 France liquid biopsy market, by biomarkers, 2016 - 2020 (USD Mn)
  • TABLE 75 France liquid biopsy market, by biomarkers, 2021 - 2027 (USD Mn)
  • TABLE 76 France liquid biopsy market, by product, 2016 - 2020 (USD Mn)
  • TABLE 77 France v biopsy market, by product, 2021 - 2027 (USD Mn)
  • TABLE 78 France Liquid biopsy market, by application, 2016 - 2020 (USD Mn)
  • TABLE 79 France Liquid biopsy market, by application, 2021 - 2027 (USD Mn)
  • TABLE 80 Spain liquid biopsy market, by biomarkers, 2016 - 2020 (USD Mn)
  • TABLE 81 Spain liquid biopsy market, by biomarkers, 2021 - 2027 (USD Mn)
  • TABLE 82 Spain liquid biopsy market, by product, 2016 - 2020 (USD Mn)
  • TABLE 83 Spain liquid biopsy market, by product, 2021 - 2027 (USD Mn)
  • TABLE 84 Spain liquid biopsy market, by application, 2016 - 2020 (USD Mn)
  • TABLE 85 Spain liquid biopsy market, by application, 2021 - 2027 (USD Mn)
  • TABLE 86 Italy liquid biopsy market, by biomarkers, 2016 - 2020 (USD Mn)
  • TABLE 87 Italy liquid biopsy market, by biomarkers, 2021 - 2027 (USD Mn)
  • TABLE 88 Italy liquid biopsy market, by product, 2016 - 2020 (USD Mn)
  • TABLE 89 Italy liquid biopsy market, by product, 2021 - 2027 (USD Mn)
  • TABLE 90 Italy liquid biopsy market, by application, 2016 - 2020 (USD Mn)
  • TABLE 91 Italy liquid biopsy market, by application, 2021 - 2027 (USD Mn)
  • TABLE 92 Asia Pacific liquid biopsy market size, by country, 2016 - 2020 (USD Mn)
  • TABLE 93 Asia Pacific liquid biopsy market size, by country, 2021 - 2027 (USD Mn)
  • TABLE 94 Asia Pacific liquid biopsy market, by biomarkers, 2016 - 2020 (USD Mn)
  • TABLE 95 Asia Pacific liquid biopsy market, by biomarkers, 2021 - 2027 (USD Mn)
  • TABLE 96 Asia Pacific liquid biopsy market, by product, 2016 - 2020 (USD Mn)
  • TABLE 97 Asia Pacific liquid biopsy market, by product, 2021 - 2027 (USD Mn)
  • TABLE 98 Asia Pacific liquid biopsy market, by application, 2016 - 2020 (USD Mn)
  • TABLE 99 Asia Pacific liquid biopsy market, by application, 2021 - 2027 (USD Mn)
  • TABLE 100 China liquid biopsy market, by biomarkers, 2016 - 2020 (USD Mn)
  • TABLE 101 China liquid biopsy market, by biomarkers, 2021 - 2027 (USD Mn)
  • TABLE 102 China liquid biopsy market, by product, 2016 - 2020 (USD Mn)
  • TABLE 103 China liquid biopsy market, by product, 2021 - 2027 (USD Mn)
  • TABLE 104 China liquid biopsy market, by application, 2016 - 2020 (USD Mn)
  • TABLE 105 China liquid biopsy market, by application, 2021 - 2027 (USD Mn)
  • TABLE 106 India liquid biopsy market, by biomarkers, 2016 - 2020 (USD Mn)
  • TABLE 107 India liquid biopsy market, by biomarkers, 2021 - 2027 (USD Mn)
  • TABLE 108 India liquid biopsy market, by product, 2016 - 2020 (USD Mn)
  • TABLE 109 India liquid biopsy market, by product, 2021 - 2027 (USD Mn)
  • TABLE 110 India liquid biopsy market, by application, 2016 - 2020 (USD Mn)
  • TABLE 111 India liquid biopsy market, by application, 2021 - 2027 (USD Mn)
  • TABLE 112 Japan liquid biopsy market, by biomarkers, 2016 - 2020 (USD Mn)
  • TABLE 113 Japan liquid biopsy market, by biomarkers, 2021 - 2027 (USD Mn)
  • TABLE 114 Japan liquid biopsy market, by product, 2016 - 2020 (USD Mn)
  • TABLE 115 Japan liquid biopsy market, by product, 2021 - 2027 (USD Mn)
  • TABLE 116 Japan liquid biopsy market, by application, 2016 - 2020 (USD Mn)
  • TABLE 117 Japan liquid biopsy market, by application, 2021 - 2027 (USD Mn)
  • TABLE 118 Latin America liquid biopsy market size, by country, 2016 - 2020 (USD Mn)
  • TABLE 119 Latin America liquid biopsy market size, by country, 2021 - 2027 (USD Mn)
  • TABLE 120 Latin America liquid biopsy market, by biomarkers, 2016 - 2020 (USD Mn)
  • TABLE 121 Latin America liquid biopsy market, by biomarkers, 2021 - 2027 (USD Mn)
  • TABLE 122 Latin America liquid biopsy market, by product, 2016 - 2020 (USD Mn)
  • TABLE 123 Latin America liquid biopsy market, by product, 2021 - 2027 (USD Mn)
  • TABLE 124 Latin America liquid biopsy market, by application, 2016 - 2020 (USD Mn)
  • TABLE 125 Latin America liquid biopsy market, by application, 2021 - 2027 (USD Mn)
  • TABLE 126 Brazil liquid biopsy market, by biomarkers, 2016 - 2020 (USD Mn)
  • TABLE 127 Brazil liquid biopsy market, by biomarkers, 2021 - 2027 (USD Mn)
  • TABLE 128 Brazil liquid biopsy market, by product, 2016 - 2020 (USD Mn)
  • TABLE 129 Brazil liquid biopsy market, by product, 2021 - 2027 (USD Mn)
  • TABLE 130 Brazil liquid biopsy market, by application, 2016 - 2020 (USD Mn)
  • TABLE 131 Brazil liquid biopsy market, by application, 2021 - 2027 (USD Mn)
  • TABLE 132 Mexico liquid biopsy market, by biomarkers, 2016 - 2020 (USD Mn)
  • TABLE 133 Mexico liquid biopsy market, by biomarkers, 2021 - 2027 (USD Mn)
  • TABLE 134 Mexico liquid biopsy market, by product, 2016 - 2020 (USD Mn)
  • TABLE 135 Mexico liquid biopsy market, by product, 2021 - 2027 (USD Mn)
  • TABLE 136 Mexico liquid biopsy market, by application, 2016 - 2020 (USD Mn)
  • TABLE 137 Mexico liquid biopsy market, by application, 2021 - 2027 (USD Mn)
  • TABLE 138 MEA liquid biopsy market size, by country, 2016 - 2020 (USD Mn)
  • TABLE 139 MEA liquid biopsy market size, by country, 2021 - 2027 (USD Mn)
  • TABLE 140 MEA liquid biopsy market, by biomarkers, 2016 - 2020 (USD Mn)
  • TABLE 141 MEA liquid biopsy market, by biomarkers, 2021 - 2027 (USD Mn)
  • TABLE 142 MEA liquid biopsy market, by product, 2016 - 2020 (USD Mn)
  • TABLE 143 MEA liquid biopsy market, by product, 2021 - 2027 (USD Mn)
  • TABLE 144 MEA liquid biopsy market, by application, 2016 - 2020 (USD Mn)
  • TABLE 145 MEA liquid biopsy market, by application, 2021 - 2027 (USD Mn)
  • TABLE 146 South Africa liquid biopsy market, by biomarkers, 2016 - 2020 (USD Mn)
  • TABLE 147 South Africa liquid biopsy market, by biomarkers, 2021 - 2027 (USD Mn)
  • TABLE 148 South Africa liquid biopsy market, by product, 2016 - 2020 (USD Mn)
  • TABLE 149 South Africa liquid biopsy market, by product, 2021 - 2027 (USD Mn)
  • TABLE 150 South Africa liquid biopsy market, by application, 2016 - 2020 (USD Mn)
  • TABLE 151 South Africa liquid biopsy market, by application, 2021 - 2027 (USD Mn)
  • TABLE 152 Saudi Arabia liquid biopsy market, by biomarkers, 2016 - 2020 (USD Mn)
  • TABLE 153 Saudi Arabia liquid biopsy market, by biomarkers, 2021 - 2027 (USD Mn)
  • TABLE 154 Saudi Arabia liquid biopsy market, by product, 2016 - 2020 (USD Mn)
  • TABLE 155 Saudi Arabia liquid biopsy market, by product, 2021 - 2027 (USD Mn)
  • TABLE 156 Saudi Arabia liquid biopsy market, by application, 2016 - 2020 (USD Mn)
  • TABLE 157 Saudi Arabia liquid biopsy market, by application, 2021 - 2027 (USD Mn)

Charts & Figures

  • FIG 1 Liquid biopsy industry 360 degree synopsis, 2016 - 2027
  • FIG 2 Industry segmentation
  • FIG 3 Global liquid biopsy industry landscape, 2016 - 2027 (USD Million)
  • FIG 4 Growth potential analysis, by biomarkers
  • FIG 5 Growth potential analysis, by product
  • FIG 6 Growth potential analysis, by application
  • FIG 7 Porter's analysis
  • FIG 8 PESTEL analysis
  • FIG 9 Key segment trends, by biomarkers
  • FIG 10 Key segment trends, by product
  • FIG 11 Key segment trends, by application
  • FIG 12 Key regional trends
  • FIG 13 Competitive dashboard, 2020